The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Olanzapine in the Treatment of Low Body Weight and Obsessive Thinking in Women With Anorexia Nervosa: A Randomized, Double-Blind, Placebo-Controlled Trial
Abstract
OBJECTIVE: Anorexia nervosa is associated with high mortality, morbidity, and treatment costs. Olanzapine, an atypical antipsychotic, is known to result in weight gain in other patient populations. The objective of this trial was to assess the efficacy of olanzapine in promoting weight gain and in reducing obsessive symptoms among adult women with anorexia nervosa. METHOD: The study was a double-blind, placebo-controlled, 10-week flexible dose trial in which patients with anorexia nervosa (N=34) were randomly assigned to either olanzapine plus day hospital treatment or placebo plus day hospital treatment. RESULTS: Compared with placebo, olanzapine resulted in a greater rate of increase in weight, earlier achievement of target body mass index, and a greater rate of decrease in obsessive symptoms. No differences in adverse effects were observed between the two treatment conditions. CONCLUSIONS: These preliminary results suggest that olanzapine may be safely used in achieving more rapid weight gain and improvement in obsessive symptoms among women with anorexia nervosa. Replication, in the form of a large multicenter trial, is recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hierarchical Linear Models: Applications and Data Analysis Methods.
Longford, N. T., Bryk, A. S., & Raudenbush, S. W. (1993) · Contemporary Sociology · doi:10.2307/2075823 · Cited by 18,724
Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence
Singer, J. D., & Willett, J. B. (2003) · doi:10.1093/acprof:oso/9780195152968.001.0001 · Cited by 10,647
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712 · cited 5×
“Yale-Brown Obsessive Compulsive Scale assessments were conducted by two clinicians who initially rated the patients separately and then came to a consensus when ratings differed.”
BackgroundMethodInfluentialMultilevel analysis techniques and applications
Hox, J. J., Moerbeek, M., & van de Schoot, R. (2002) · Cited by 6,734
Gill, J. (2005) · Encyclopedia of Social Measurement · doi:10.1016/b0-12-369398-5/00166-3 · Cited by 3,114
Hox, J., Moerbeek, M., & van de Schoot, R. (2002) · doi:10.4324/9781410604118 · Cited by 2,419
Gueorguieva, R., & Krystal, J. H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.310 · Cited by 1,529
Handbook of treatment for eating disorders
(1997) · Choice Reviews Online · doi:10.5860/choice.35-2151 · Cited by 1,076
Mortality in anorexia nervosa.
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.1073 · Cited by 974 · cited 1×
“The severe weight loss, associated medical complications, psychological morbidity, and chronic course of the illness result in anorexia nervosa having the highest mortality rate among all psychiatric disorders (2).”
Background(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.457 · Cited by 891
Psychological treatment of eating disorders.
Wilson, G. T., Grilo, C. M., & Vitousek, K. M. (2007) · American Psychologist · doi:10.1037/0003-066x.62.3.199 · Cited by 645
Does Fluoxetine Augment the Inpatient Treatment of Anorexia Nervosa?
Attia, E., Haiman, C., Walsh, B. T., & Flater, S. R. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.4.548 · Cited by 324
Antipsychotic Metabolic Effects: Weight Gain, Diabetes Mellitus, and Lipid Abnormalities
McIntyre, R. S., McCann, S. M., & Kennedy, S. H. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600308 · Cited by 261
Tollefson, G. D., Sanger, T. M., Lu, Y., & Thieme, M. E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.250 · Cited by 261
Metabolic side effects of antipsychotic medication
Tschoner, A., Engl, J., Laimer, M., Kaser, S., Rettenbacher, M., Fleischhacker, W. W., Patsch, J. R., & Ebenbichler, C. F. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01416.x · Cited by 253
Drs. Sullivan and Youngner Reply
SULLIVAN, M. D., & YOUNGNER, S. J. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.10.1533 · Cited by 251
EPIDEMIOLOGY OF THE EATING DISORDERS
Hsu, L. K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70375-0 · Cited by 251
Vandereycken, W., & Pierloot, R. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb04501.x · Cited by 175
Day hospitalization programs for eating disorders: A systematic review of the literature
Zipfel, S., Reas, D. L., Thornton, C., Olmsted, M. P., Williamson, D. A., Gerlinghoff, M., Herzog, W., & Beumont, P. J. V. (2002) · International Journal of Eating Disorders · doi:10.1002/eat.10009 · Cited by 171
Handbook of treatment for eating disorders, 2nd ed.
Garner, D. M., & Garfinkel, P. E. (1997) · Cited by 163
Olanzapine therapy in anorexia nervosa: psychobiological effects
Brambilla, F., Garcia, C. S., Fassino, S., Daga, G. A., Favaro, A., Santonastaso, P., Ramaciotti, C., Bondi, E., Mellado, C., Borriello, R., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328080ca31 · Cited by 156 · cited 1×
“Recently, a randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of anorexia nervosa (23) was conducted using repeated measures analysis of variance (ANOVA), an analytic approach to longitudinal data with known disadvantages (24).”
MethodTreatment and outcome of anorexia nervosa.
Dally, P., & Sargant, W. (1966) · BMJ · doi:10.1136/bmj.2.5517.793 · Cited by 151
Olanzapine in the treatment of anorexia nervosa: An open label trial
Powers, P. S., Santana, C. A., & Bannon, Y. (2002) · International Journal of Eating Disorders · doi:10.1002/eat.10084 · Cited by 150
Vandereycken, W. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.144.3.288 · Cited by 149
Randomized Controlled Trial of Olanzapine in the Treatment of Cognitions in Anorexia Nervosa
Mondraty, N., Laird Birmingham, C., Touyz, S., Sundakov, V., Chapman, L., & Beumont, P. (2005) · Australasian Psychiatry · doi:10.1080/j.1440-1665.2004.02154.x · Cited by 130
Prediction of Outcome in Bulimia Nervosa by Early Change in Treatment
Fairburn, C. G., Agras, W. S., Walsh, B. T., Wilson, G. T., & Stice, E. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2322 · Cited by 130
Howard, W. T., Evans, K. K., Quintero-Howard, C. V., Bowers, W. A., & Andersen, A. E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1697 · Cited by 127
A New Treatment of Anorexia Nervosa
Dally, P. J., & Sargant, W. (1960) · BMJ · doi:10.1136/bmj.1.5188.1770 · Cited by 116
Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?
Ferguson, C. P., Via, M. C. L., Crossan, P. J., & Kaye, W. H. (1999) · International Journal of Eating Disorders · doi:10.1002/(sici)1098-108x(199901)25:1<11::aid-eat2>3.0.co;2-u · Cited by 115
Psychosocial and pharmacological treatment of eating disorders: A review of research findings
Peterson, C. B., & Mitchell, J. E. (1999) · Journal of Clinical Psychology · doi:10.1002/(sici)1097-4679(199906)55:6<685::aid-jclp3>3.0.co;2-y · Cited by 111
An Open Trial of Olanzapine in Anorexia Nervosa
Barbarich, N. C., McConaha, C. W., Gaskill, J. A., Via, M. L., Frank, G., Achenbach, S., Plotnicov, K. H., & Kaye, W. H. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1106 · Cited by 103
Obsessive compulsive disorders in eating disorders
Speranza, M., Corcos, M., Godart, N. T., Loas, G., Guilbaud, O., Jeammet, P., & Flament, M. F. (2001) · Eating Behaviors · doi:10.1016/s1471-0153(01)00035-6 · Cited by 101
Tasca, G. A., Taylor, D., Ritchie, K., & Balfour, L. (2004) · Journal of Personality Assessment · doi:10.1207/s15327752jpa8303_04 · Cited by 90
Self-citationPersonality Assessment Inventory ( PAI )
Morey, L. C. (2015) · The Encyclopedia of Clinical Psychology · doi:10.1002/9781118625392.wbecp284 · Cited by 75
Treating Eating Disorders: Ethical, Legal and Personal Issues
Stewart, A. (1999) · Journal of Medical Ethics · doi:10.1136/jme.25.6.552 · Cited by 66
The Role of Olanzapine in the Treatment of Anorexia Nervosa
Dunican, K. C., & DelDotto, D. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h297 · Cited by 55
Short-term outcome of psychiatric inpatients with anorexia nervosa in the current care environment
Treat, T. A., Gaskill, J. A., McCabe, E. B., Ghinassi, F. A., Luczak, A. D., & Marcus, M. D. (2005) · International Journal of Eating Disorders · doi:10.1002/eat.20160 · Cited by 39
Strober, M. A., Pataki, C. S., Freeman, R., & DeAntonio, M. (1999) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1999.9.195 · Cited by 32
Simpson, H. B., Petkova, E., Cheng, J., Huppert, J. D., Foa, E. B., & Liebowitz, M. R. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.07.012 · Cited by 17
(2000) · doi:10.1002/(sici)1098-108x(200004)27:3
Cited by
A systematic review of personality trait change through intervention.
Roberts, B. W., Luo, J., Briley, D. A., Chow, P. I., Su, R., & Hill, P. L. (2017) · Psychological Bulletin · doi:10.1037/bul0000088 · Cited by 1,047
New insights into symptoms and neurocircuit function of anorexia nervosa
Kaye, W. H., Fudge, J. L., & Paulus, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2682 · Cited by 843
“Preliminary data raise the possibility that olanzapine (Zyprexa; eli lilly) — which has effects on both DA and 5-HT receptors — and possibly other atypical antipsychotics might be useful for increasing weight gain and reducing anxiety and obsessionality in AN 99 .”
Treasure, J., Claudino, A. M., & Zucker, N. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61748-7 · Cited by 658
Identification and Management of Eating Disorders in Children and Adolescents
Rosen, D. S., & the Committee on Adolescence (2010) · Pediatrics · doi:10.1542/peds.2010-2821 · Cited by 370
Watson, H. J., & Bulik, C. M. (2013) · Psychological Medicine · doi:10.1017/s0033291712002620 · Cited by 339
Metadata
- Authors
- Bissada, H., Tasca, G. A., Barber, A. M., & Bradwejn, J.
- Venue
- American Journal of Psychiatry
- Published
- 2008-10
- Volume
- 165
- Issue
- 10
- Pages
- 1281-1288
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2070200231
- Cited by
- 268
- References
- 40
- FWCI
- 24.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.